
Next-gen flu vaccines use proteolysis-targeting to boost safety and cross-strain immunity in animal models
Recently, Prof. Si Longlong’s team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize diverse E3 ubiquitin ligases to degrade viral […]